DroSpas · DroSpas-1

Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.

A Phase III, Multi-centre, Randomised, Double-blind, Placebo-controlled, Parallel-group Clinical Trial to Investigate the Efficacy and Safety of BX-1 for the Symptomatic Relief of Spasticity in Patients With Multiple Sclerosis (MS) EudraCT 2018-000001-23

Sponsor: BIONORICA

Phase: III

Area: Neuroimmunology

Open the current study catalogue